1. Barbeau A (1974) The clinical physiology of side effects in long term l-dopa therapy. Adv Neurol 5: 347?365
2. Bianchine JR, Shaw GM (1976) Clinical pharmacokinetics of levodopa in Parkinson's disease. Clin Pharmacokinet 1: 313?338
3. Birkmayer W, Danielcyk W, Neunayer E, Riederer P (1973) L-dopa level in plasma, primary condition for the kinetic effect. J Neurotrans 34: 133?143
4. Da Prada M, Ketteler R, Haefely W (1979) Effect of benserazide and carbidopa on the concentration of endogenous dopa in human and rat plasma. Naunyn Schmiedebergs Arch Pharmacol 307: R61
5. Doller HJ, Connor JD, Lock DR, Sloviter RS, Dvorchik BH, Vesell ES (1978) Levodopa pharmacokinetics: Alteration after benserazide, a decarboxylase inhibitor. Drug Metab Dispos 6: 164?168